Jim Cramer Wants Novo Nordisk A/S (NYSE:NVO) To Compete With Eli Lilly In The Market & Not The Courts

Notice · Comments reflect the author's own views, not those of this site. Posts that violate applicable laws (defamation, hate speech, misinformation, etc.) may be removed without notice. By posting you agree to our terms of use.